Statistics

Total Visits

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation37

Select a period of time:

Number of views in the range

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation21

Views

Views
January 20250
February 20255
March 202513
April 20252
May 20250
June 20250
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States3
Brazil1
Spain1
 

Top cities views

Views
Buffalo1
Council Bluffs1
São José do Egito1